Howard M. Katzenstein, Kay W. Chang, Mark Krailo, Zhengjia Chen, Milton J. Finegold, Jon Rowland, Marleta Reynolds, Alberto Pappo, Wendy B. London and Marcio Malogolowkin Amifostine does not prevent platinum-induced hearing loss associated with the treatment of children with hepatoblastoma Cancer 115
Article first published online: 7 OCT 2009 | DOI: 10.1002/cncr.24667
Amifostine in the doses and schedule used in Children's Oncology Group Study P9645 failed to significantly reduce the incidence of hearing loss and other platinum-induced toxicities in patients with hepatoblastoma.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field